What Are Investors Missing as Liquidia and Arcutis Stocks Rally 34% and 27% in a Week on Settlement News and Sales Growth?
What Are Investors Missing About LiveRamp at a Low P/E as the FTC Sets Conditions on the Publicis Deal?
Five names lead the intraday decliners on October 21: Callan JMB (NASDAQ:CJMB) is trading down 33.73% at $0.4373, Alpha Teknova (NASDAQ:TKNO) is trading down 32.54% at $4.99, NewGenIvf Group (NASDAQ:NIVF) is trading down 21.93% at $0.1951, INLIF (NASDAQ:INLF) is trading down 19.59% at $0.2102 …
Lucid Diagnostics (NASDAQ:LUCD) is trading up 9.58% at $0.3856 on October 21, and no company announcement was identified for October 20 or 21. The most recent dated company news is the May 14 first-quarter release, so the move cannot be tied to a disclosed …
Macy's (NYSE:M) is trading down 0.45% at $23.32 on October 21, and no company announcement was identified for the session. The only item found was a report of unusually heavy bearish put option activity around October 20, with put volume at roughly 56 times …
What Are Investors Missing as Marwynn Holdings Falls 11.67% With No Company Announcement Identified?
Match Group (NASDAQ:MTCH) is trading down 0.61% at $46.24 on October 21, and no company announcement was identified for the session. The move follows a 4.02% rise on October 20 to $46.53, when Evercore ISI upgraded the shares to Outperform from In Line with …
Maze Therapeutics (NASDAQ:MAZE) closed up 9.26% at $32.45 on October 20 and is up 17.83% over the week, for a market capitalization of about $1.80 billion. The stock has gained 39.45% over the past month, which means much of its advance predates this week. …
Five penny stocks are rising in a medtech and diagnostics group on October 21. Lucid Diagnostics (NASDAQ:LUCD) is trading up 9.58% at $0.3856, Ainos (NASDAQ:AIMD) is up 9.95% at $0.9899, TELA Bio (NASDAQ:TELA) is up 8.72% at $1.19, Baird Medical (NASDAQ:BDMD) is up 13.97% …
Melar Acquisition I (NASDAQ:MACI) was trading up 8.91% at $12.10 on October 21, and no company announcement was identified for the session. The question for investors is what the move may be reflecting, and the most relevant context is a tight timetable. Shareholders extended …